NutraLife Biosciences, Inc. Begins Manufacturing Sanitizers Amid the COVID-19 Global Pandemic

Coconut Creek, FL, March 30, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NutraLife Biosciences, Inc. (the “Company” or “NutraLife”) (OTC: NLBS) announced today that it is converting the Company’s existing nutraceutical bottling manufacturing operation to produce sanitizer products.
Amid the global pandemic of COVID-19, NutraLife has increased its scope of production in accordance with 21 CFR 211–Current Good Manufacturing Practices for Finished Pharmaceuticals and has been assigned its labeler code from the Food and Drug Administration (“FDA”) in order to operate as an over-the-counter manufacturer. NutraLife is taking all necessary steps to ramp up production while adhering to FDA guidelines for the production, packaging, labeling, and distribution of the sanitizer products. NutraLife plans to operate multiple shifts daily to aid in the current shortage of sanitizer products while keeping its employees safe and employed as an essential business during this time of need. The Company is currently in the production of Eddie’s Clean Hands Sanitizing Spray, which is an alcohol-based sanitizer with soothing emollients such as aloe and glycerin in order to prevent excessive skin drying and is scented with natural, artisan lavender oil. The sanitizer can be applied to hands or surfaces. Moving forward, NutraLife will continue to develop alternative delivery methods to meet consumer preference in forms of gels or foaming sanitizers. The current liquid spray in production features 2oz. and 8oz. formats for increased convenience. eddiescleanhands.comAbout the CompanyNutraLife Biosciences, Inc. operates a multifaceted life sciences company. For more than 6 years the Company has manufactured and distributed private label and branded nutraceutical and skincare wellness products. Forward-Looking StatementsThis press release contains statements of a forward-looking nature about NutraLife Biosciences, Inc. (the “Company”). These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions.  The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that the Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the Section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission on April 2, 2019. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statements. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.Contact:
info@nutralifebiosciences.comAttachmentNLBS